168 related articles for article (PubMed ID: 24375191)
1. Association between TP53 Arg72Pro polymorphism and thyroid carcinoma risk.
Wang F; Wang P; Wang B; Fu ZJ; Yuan Y; Yan SL; Zhao WJ; Wang YG
Tumour Biol; 2014 Mar; 35(3):2723-8. PubMed ID: 24375191
[TBL] [Abstract][Full Text] [Related]
2. Association between p53 Arg72Pro polymorphism and thyroid cancer risk: a meta-analysis.
Wu B; Guo D; Guo Y
Tumour Biol; 2014 Jan; 35(1):561-5. PubMed ID: 24037912
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and risk of glioma.
Zhang F; Li D; Li Y; Li H; Sun J; Li X; Li X
Tumour Biol; 2014 Jan; 35(1):747-51. PubMed ID: 24046089
[TBL] [Abstract][Full Text] [Related]
4. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and bladder cancer risk.
Liu ZH; Bao ED
Mol Biol Rep; 2013 Mar; 40(3):2389-95. PubMed ID: 23184052
[TBL] [Abstract][Full Text] [Related]
5. Association between TP53 Arg72Pro polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Xu CT; Zheng F; Dai X; Du JD; Liu HR; Zhao L; Li WM
Asian Pac J Cancer Prev; 2012; 13(9):4305-9. PubMed ID: 23167333
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of association between the TP53 Arg72Pro polymorphism and risk of endometriosis based on case-control studies.
Yan Y; Wu R; Li S; He J
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():1-7. PubMed ID: 25819169
[TBL] [Abstract][Full Text] [Related]
7. Association between TP53 Arg72Pro polymorphism and leukemia risk: a meta-analysis of 14 case-control studies.
Tian X; Dai S; Sun J; Jiang S; Jiang Y
Sci Rep; 2016 Apr; 6():24097. PubMed ID: 27053289
[TBL] [Abstract][Full Text] [Related]
8. TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis.
Jiang DK; Yao L; Wang WZ; Peng B; Ren WH; Yang XM; Yu L
World J Gastroenterol; 2011 Mar; 17(9):1227-33. PubMed ID: 21448430
[TBL] [Abstract][Full Text] [Related]
9. Associations between P53 Arg72Pro and development of digestive tract cancers: a meta-analysis.
Liu L; Wang K; Zhu ZM; Shao JH
Arch Med Res; 2011 Jan; 42(1):60-9. PubMed ID: 21376265
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the p53 Arg72Pro polymorphism and its association with cancer risk: a HuGE review and meta-analysis.
Khan MH; Khalil A; Rashid H
Genet Res (Camb); 2015 Apr; 97():e7. PubMed ID: 25882871
[TBL] [Abstract][Full Text] [Related]
11. Association between the TP53 codon 72 polymorphism and risk of oral squamous cell carcinoma in Asians: a meta-analysis.
Zeng XT; Luo W; Geng PL; Guo Y; Niu YM; Leng WD
BMC Cancer; 2014 Jun; 14():469. PubMed ID: 24969046
[TBL] [Abstract][Full Text] [Related]
12. Pro variant of TP53 Arg72Pro contributes to esophageal squamous cell carcinoma risk: evidence from a meta-analysis.
Wang B; Wang D; Zhang D; Li A; Liu D; Liu H; Jin H
Eur J Cancer Prev; 2010 Jul; 19(4):299-307. PubMed ID: 20389250
[TBL] [Abstract][Full Text] [Related]
13. TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis.
Jiang DK; Yao L; Ren WH; Wang WZ; Peng B; Yu L
Med Oncol; 2011 Dec; 28(4):1129-35. PubMed ID: 20552298
[TBL] [Abstract][Full Text] [Related]
14. TP53 Arg72Pro polymorphism (rs1042522) and risk of endometriosis among Asian and Caucasian populations.
Li J; Chen Y; Mo Z; Li L
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():73-8. PubMed ID: 25889195
[TBL] [Abstract][Full Text] [Related]
15. p.Arg72Pro polymorphism of P53 and breast cancer risk: a meta-analysis of case-control studies.
Diakite B; Kassogue Y; Dolo G; Wang J; Neuschler E; Kassogue O; Keita ML; Traore CB; Kamate B; Dembele E; Nadifi S; Murphy RL; Doumbia S; Hou L; Maiga M
BMC Med Genet; 2020 Oct; 21(1):206. PubMed ID: 33076844
[TBL] [Abstract][Full Text] [Related]
16. Significant associations between X-ray repair cross-complementing group 3 genetic polymorphisms and thyroid cancer risk.
Yu XL; Liu H; Wang B; Fu ZJ; Yuan Y; Yan SL; Zhao WJ; Wang YG; Cai J
Tumour Biol; 2014 Mar; 35(3):2009-15. PubMed ID: 24277376
[TBL] [Abstract][Full Text] [Related]
17. Association between TP53 gene codon72 polymorphism and prostate cancer risk: A systematic review and meta-analysis.
Han PZ; Cao DH; Zhang XL; Ren ZJ; Wei Q
Medicine (Baltimore); 2019 Jun; 98(25):e16135. PubMed ID: 31232967
[TBL] [Abstract][Full Text] [Related]
18. Arg72Pro polymorphism of TP53 gene and the risk of skin cancer: a meta-analysis.
Ye J; Li XF; Wang YD; Yuan Y
PLoS One; 2013; 8(11):e79983. PubMed ID: 24260330
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of associations between the TP53 Arg72Pro polymorphism with risk of head and neck carcinomas based on case-control studies.
Ren WH; Jiang DK; Pei Y; Wang SQ; Yang XM; Yu L
Genet Mol Res; 2014 Jan; 13(1):103-14. PubMed ID: 24446292
[TBL] [Abstract][Full Text] [Related]
20. p53 Arg72Pro polymorphism confers the susceptibility to endometriosis among Asian and Caucasian populations.
Lao X; Chen Z; Qin A
Arch Gynecol Obstet; 2016 May; 293(5):1023-31. PubMed ID: 26493553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]